INS and obesity disorder: In mouse models of obesity/diabetes, increased glucose intolerance, reduced serum insulin levels, and reduced tissue glucose uptake after chemerin administration were observed [98], despite the fact that some studies suggested that chemerin is necessary for the proper insulin production by the pancreas [99,100].